CDYMAX (INDIA) PHARMA PRIVATE LIMITED – FDA Inspection, Feb 28, 2025

Record Details

This FDA Inspection record concerns CDYMAX (INDIA) PHARMA PRIVATE LIMITED, with an inspection on February 28, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: CDYMAX (INDIA) PHARMA PRIVATE LIMITED
Inspection Date: February 28, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Eileen A. Liu

View Company Profile

ID · ff4d2eca-10f8-4a4f-af89-e69006d5d06a

Inspection Facts

Inspection number: 1265529
FDA center: Human Drugs
Outcome: Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CDYMAX (INDIA) PHARMA PRIVATE LIMITED

FDA Inspection

CDYMAX (INDIA) PHARMA PRIVATE LIMITEDFebruary 28, 2025

CDYMAX (INDIA) PHARMA PRIVATE LIMITED – FDA Inspection, Feb 28, 2025

Record Details

This FDA Inspection record concerns CDYMAX (INDIA) PHARMA PRIVATE LIMITED, with an inspection on February 28, 2025, issued by the Office of Inspections and Investigations, covering human drugs.